Efficacy and safety of a combination of metformin and rosiglitaone in patients with type 2 diabetes mellitus--a postmarketing study.
J Indian Med Assoc
;
2003 Feb; 101(2): 113-4, 123
Article
Dans Anglais
| IMSEAR
| ID: sea-105706
ABSTRACT
The efficacy and safety of combined metformin and rosiglitazone therapy in type 2 diabetes has been evaluated in an open-label, phase IV, prospective, multicentre study conducted in India over a period of 3 months in accordance with the principles of Good Clinical Practice and the Declaration of Helsinki. The superiority of the combination therapy in its effects on glycaemic parameters and lipid profile has been observed. A discussion of the same with brief review of literature has been presented here.
Texte intégral:
Disponible
Indice:
IMSEAR (Asie du Sud-Est)
Sujet Principal:
Surveillance post-commercialisation des produits de santé
/
Thiazoles
/
Sujet âgé
/
Femelle
/
Humains
/
Mâle
/
Études prospectives
/
Analyse de variance
/
Résultat thérapeutique
/
Adulte
Type d'étude:
Essai clinique contrôlé
/
Étude observationnelle
langue:
Anglais
Texte intégral:
J Indian Med Assoc
Année:
2003
Type:
Article
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS